OneOncology is a partnership of independent community oncology practices committed to driving the future of cancer care delivery. With access to capital, practice partners, and resources, OneOncology helps make patient care their number one priority. Their headquarters is located in Nashville, Tennessee, and they have recently completed a funding round. OneOncology provides comprehensive services that allow them to provide high-quality, evidence-based, personalized care for patients.
They have developed disease-specific pathways for many types of cancer, including non-small cell lung cancer, renal cell cancer and prostate cancer. These pathways are updated frequently based on the most recent data and are consistent with many national evidence-based guidelines. In addition to providing personalized care for patients, OneOncology also helps partner offices expand their services throughout the continuity of cancer care. This includes screening and diagnosis, clinical trials, therapies, survival and end-of-life care.
For World Cancer Day, Dr. Jeff Patton discussed the impact of COVID-19 on cancer treatment and testing in an interview with Targeted Oncology. OneOncology was founded by community oncologists with a mission to improve the lives of all people living with cancer. It is comprised of five large community cancer offices that represent more than 400 providers who practice in more than 160 centers of care in the United States.
Through The US Oncology Network (The Network), physicians have access to resources, best business practices, and the expertise, infrastructure and support of McKesson. At OneOncology, they strive to provide comprehensive services that allow them to provide high-quality, evidence-based, personalized care for patients. With access to capital, practice partners, and resources, OneOncology helps make patient care their number one priority.
